Spermatogenesis arrest

Spermatogenesis arrest is a condition characterized by the interruption or cessation of spermatogenesis, the process by which spermatozoa are produced from spermatogonial stem cells in the seminiferous tubules of the testes. This condition can lead to male infertility due to the inability to produce mature sperm cells.
Causes[edit]
Spermatogenesis arrest can be caused by a variety of factors, including:
- Genetic disorders such as Klinefelter syndrome and Y chromosome microdeletions
- Hormonal imbalances, particularly involving testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH)
- Environmental factors such as exposure to radiation, chemotherapy, and certain toxins
- Infections and inflammation of the testes, such as orchitis
- Varicocele, an abnormal enlargement of the pampiniform plexus in the scrotum
- Cryptorchidism, a condition where one or both testes fail to descend into the scrotum
Diagnosis[edit]
The diagnosis of spermatogenesis arrest typically involves a combination of:
- Medical history and physical examination
- Semen analysis to evaluate sperm count, motility, and morphology
- Hormonal assays to measure levels of FSH, LH, and testosterone
- Testicular biopsy to directly examine the seminiferous tubules and identify the stage at which spermatogenesis is arrested
Treatment[edit]
Treatment options for spermatogenesis arrest depend on the underlying cause and may include:
- Hormone therapy to correct hormonal imbalances
- Surgical correction of conditions such as varicocele or cryptorchidism
- Assisted reproductive technologies (ART) such as intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF)
- Lifestyle modifications to reduce exposure to environmental toxins and improve overall health
Prognosis[edit]
The prognosis for individuals with spermatogenesis arrest varies depending on the cause and the effectiveness of treatment. Some men may achieve successful fertility with appropriate interventions, while others may require ongoing ART to conceive.
See also[edit]
References[edit]
External links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
